Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Faulkner Hospital
mi
from
Boston, MA
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Faulkner Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Good Samaritan Hospital, San Jose
mi
from
San Jose, CA
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Good Samaritan Hospital, San Jose
mi
from
San Jose, CA
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Marin General Hospital
mi
from
Greenbrae, CA
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Marin General Hospital
mi
from
Greenbrae, CA
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Massachusetts General Hospital
mi
from
Boston, MA
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Norton Healthcare Pavilion
mi
from
Louisville, KY
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Norton Healthcare Pavilion
mi
from
Louisville, KY
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Presbyterian Medical Center
mi
from
Charlotte, NC
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Presbyterian Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
South Nassau Communities Hospital
mi
from
Oceanside, NY
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
South Nassau Communities Hospital
mi
from
Oceanside, NY
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Susan Downey
mi
from
Los Angeles, CA
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Susan Downey
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Sutter Healthcare-Sacramento
mi
from
Sacramento, CA
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Sutter Healthcare-Sacramento
mi
from
Sacramento, CA
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
University of California, Irvine Medical Center
mi
from
Orange, CA
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
University of California, Irvine Medical Center
mi
from
Orange, CA
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
eSSe Plastic Surgery
mi
from
Fort Lauderdale, FL
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
eSSe Plastic Surgery
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
University of Massachusetts Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated:  11/5/2015
Methodist Hospital
mi
from
Houston, TX
Patient Controlled Tissue Expansion for Breast Reconstruction
AirXpanders Patient Activated Controlled Tissue Expander System for Breast Reconstruction
Status: Enrolling
Updated: 11/5/2015
Methodist Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
A Phase II Study to Evaluate the Efficacy, Safety, and Genomic Markers of Response of Capecitabine as NeoAdjuvant Therapy in Women With Newly Diagnosed Locally Advanced Breast Cancer
Status: Enrolling
Updated:  11/5/2015
University of Chicago
mi
from
Chicago, IL
Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
A Phase II Study to Evaluate the Efficacy, Safety, and Genomic Markers of Response of Capecitabine as NeoAdjuvant Therapy in Women With Newly Diagnosed Locally Advanced Breast Cancer
Status: Enrolling
Updated: 11/5/2015
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
A Phase II Study to Evaluate the Efficacy, Safety, and Genomic Markers of Response of Capecitabine as NeoAdjuvant Therapy in Women With Newly Diagnosed Locally Advanced Breast Cancer
Status: Enrolling
Updated:  11/5/2015
University of Ibadan
mi
from
Ibadan,
Capecitabine as NeoAdjuvant Therapy in Locally Advanced Breast Cancer
A Phase II Study to Evaluate the Efficacy, Safety, and Genomic Markers of Response of Capecitabine as NeoAdjuvant Therapy in Women With Newly Diagnosed Locally Advanced Breast Cancer
Status: Enrolling
Updated: 11/5/2015
University of Ibadan
mi
from
Ibadan,
Click here to add this to my saved trials
Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions
The Process and Outcomes of Treatment Decision-Making Communication Between Oncologists and Newly Diagnosed Female Breast-Cancer Patients
Status: Enrolling
Updated:  11/5/2015
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Treatment Decision Making Between Oncologists and Women With Newly Diagnosed Breast Cancer and Their Healthy Companions
The Process and Outcomes of Treatment Decision-Making Communication Between Oncologists and Newly Diagnosed Female Breast-Cancer Patients
Status: Enrolling
Updated: 11/5/2015
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT)
Psychoeducation For BMT Caregivers: Biobehavioral Markers and Outcome
Status: Enrolling
Updated:  11/6/2015
University of Colorado Cancer Center at UC Health Sciences Center
mi
from
Aurora, CO
Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT)
Psychoeducation For BMT Caregivers: Biobehavioral Markers and Outcome
Status: Enrolling
Updated: 11/6/2015
University of Colorado Cancer Center at UC Health Sciences Center
mi
from
Aurora, CO
Click here to add this to my saved trials
Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT)
Psychoeducation For BMT Caregivers: Biobehavioral Markers and Outcome
Status: Enrolling
Updated:  11/6/2015
Presbyterian/St. Luke's Medical Center (PSLMC) - Denver Midtown
mi
from
Denver, CO
Stress Management Intervention for Caregivers of Patients Undergoing Bone Marrow Transplant (BMT)
Psychoeducation For BMT Caregivers: Biobehavioral Markers and Outcome
Status: Enrolling
Updated: 11/6/2015
Presbyterian/St. Luke's Medical Center (PSLMC) - Denver Midtown
mi
from
Denver, CO
Click here to add this to my saved trials
Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases
Phase II Evaluation of Imiquimod, a Topical Toll-like Receptor 7 (TLR7) Agonist in Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases
Status: Enrolling
Updated:  11/6/2015
NYU Cancer Institute
mi
from
New York, NY
Imiquimod for Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases
Phase II Evaluation of Imiquimod, a Topical Toll-like Receptor 7 (TLR7) Agonist in Breast Cancer Patients With Chest Wall Recurrence or Skin Metastases
Status: Enrolling
Updated: 11/6/2015
NYU Cancer Institute
mi
from
New York, NY
Click here to add this to my saved trials
Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid Tumors
A Phase 1 Study to Evaluate the Cardiac Safety of Orally Administered TAS-102 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated:  11/6/2015
Sarah Cannon Research Institute
mi
from
Nashville, TN
Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid Tumors
A Phase 1 Study to Evaluate the Cardiac Safety of Orally Administered TAS-102 in Patients With Advanced Solid Tumors
Status: Enrolling
Updated: 11/6/2015
Sarah Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer
Positron Mammographic Imaging (PMI)
Status: Enrolling
Updated:  11/6/2015
Case Comprehensive Cancer Center
mi
from
Cleveland, OH
PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer
Positron Mammographic Imaging (PMI)
Status: Enrolling
Updated: 11/6/2015
Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Capecitabine in Women With Operable Breast Cancer
A Phase II Study of Preoperative Capecitabine in Women With Operable Breast Cancer
Status: Enrolling
Updated:  11/9/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Capecitabine in Women With Operable Breast Cancer
A Phase II Study of Preoperative Capecitabine in Women With Operable Breast Cancer
Status: Enrolling
Updated: 11/9/2015
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Capecitabine in Women With Operable Breast Cancer
A Phase II Study of Preoperative Capecitabine in Women With Operable Breast Cancer
Status: Enrolling
Updated:  11/9/2015
Faulkner Hospital
mi
from
Boston, MA
Capecitabine in Women With Operable Breast Cancer
A Phase II Study of Preoperative Capecitabine in Women With Operable Breast Cancer
Status: Enrolling
Updated: 11/9/2015
Faulkner Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Capecitabine in Women With Operable Breast Cancer
A Phase II Study of Preoperative Capecitabine in Women With Operable Breast Cancer
Status: Enrolling
Updated:  11/9/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Capecitabine in Women With Operable Breast Cancer
A Phase II Study of Preoperative Capecitabine in Women With Operable Breast Cancer
Status: Enrolling
Updated: 11/9/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Birmingham, AL
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Anchorage, AK
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Anchorage, AK
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Tucson, AZ
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Hot Springs, AR
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Hot Springs, AR
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Bakersfield, CA
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Palm Springs, CA
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Palm Springs, CA
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Aurora, CO
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Washington,
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Washington,
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Daytona Beach, FL
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Daytona Beach, FL
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Decatur, IL
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Decatur, IL
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
New Albany, IN
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
New Albany, IN
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Baltimore, MD
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Minneapolis, MN
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Livingston, NJ
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Livingston, NJ
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
New York, NY
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Syracuse, NY
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Syracuse, NY
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Portland, OR
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Houston, TX
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
San Antonio, TX
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
Clinical Research Facility
mi
from
Tacoma, WA
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
Clinical Research Facility
mi
from
Tacoma, WA
Click here to add this to my saved trials
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated:  11/11/2015
mi
from
Toronto,
Evaluation of a New Agent for Treatment of Advanced Stage Breast Cancer
Phase 2 Study to Investigate the Efficacy and Safety of ZK-Epothilone (ZK-Epo; ZK 219477) in Patients With Metastatic Breast Cancer
Status: Enrolling
Updated: 11/11/2015
mi
from
Toronto,
Click here to add this to my saved trials
Quality of Life in African-American or Caucasian Female Breast Cancer Survivors
Survey of the Quality of Life of Women
Status: Enrolling
Updated:  11/12/2015
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Quality of Life in African-American or Caucasian Female Breast Cancer Survivors
Survey of the Quality of Life of Women
Status: Enrolling
Updated: 11/12/2015
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer
L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer
Status: Enrolling
Updated:  11/13/2015
Eastern Regional Medical Center
mi
from
Philadelphia, PA
L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer
L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer
Status: Enrolling
Updated: 11/13/2015
Eastern Regional Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
Randomized Trial of Palliative Radiation Therapy for Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life
Status: Enrolling
Updated:  11/14/2015
University of Alabama at Birmingham, Comprehensive Cancer Center
mi
from
Birmingham, AL
Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
Randomized Trial of Palliative Radiation Therapy for Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life
Status: Enrolling
Updated: 11/14/2015
University of Alabama at Birmingham, Comprehensive Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials